BLRX vs CLGN: Side-by-Side Comparison
Compare Bioline Rx Ltd (BLRX) and CollPlant Biotechnologies Ltd New (CLGN) side by side: market cap USD 14.29M vs USD 4.91M. Financials, growth and model signals on Bullrun.
| Metric | BLRX | CLGN |
|---|---|---|
| Company | Bioline Rx Ltd | CollPlant Biotechnologies Ltd New |
| Country / Exchange | Israel · NASDAQ | Israel · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | USD 14.29M | USD 4.91M |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (latest FY) | — | USD 2.37M |
| Revenue growth YoY | — | +360.4% |
| Net income | — | USD -11.49M |
| Gross margin | — | 64.8% |
| Diluted EPS | — | -0.94 |